[Adenosine and methylxanthines in the central nervous system--on their significance for psychiatry and neurology].
In the last 15 years the central effects of adenosine and its importance for neurology and psychiatry have increasingly become an object of investigation. Physiology and metabolism of adenosine have been examined by different research groups. The effects of adenosine in the central nervous system and the various mechanisms of these effects have been described by electrophysiologic methods. The inhibition of the release of several neurotransmitters through adenosine has already been described 10 years ago. In this review studies on binding sites for adenosine receptor ligands are discussed thoroughly. The properties and the highly specific distribution of the distinct receptor subtypes are described. For the functioning of the adenosinergic system the different interactions with other centrally active substances such as benzodiazepines, barbiturates, neuroleptics, anti-depressants, opiates, alcohol and carbamazepine have turned out to be of interest. The results of neuropsychiatric investigations on methylxanthines, which are antagonists at the adenosine receptor, are widely considered. Finally the discussion on the importance of the adenosinergic system in different neurological and psychiatric diseases is summed up. The particular significance of adenosine in the modulation of dopaminergic functions is emphasised.
Psychiatrische Klinik, Universität München.
A
A
Erfurth
M
M
Schmauss
D000241:Adenosine / Q000502:physiology*; D001921:Brain / Q000187:drug effects*; D006801:Humans; D011619:Psychotropic Drugs / Q000008:administration & dosage*; D011983:Receptors, Purinergic / Q000187:drug effects*; D019966:Substance-Related Disorders / Q000503:physiopathology*; D014970:Xanthines / Q000009:adverse effects*
D011619:Psychotropic Drugs; D011983:Receptors, Purinergic; D014970:Xanthines; D000241:Adenosine
Adenosin und Methylxanthine im Zentralnervensystem--zur Bedeutung für Psychiatrie und Neurologie.